Completed
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
NCT00051012
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
- Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia
- Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia
- Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia